Cargando…

The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment

Invasion and metastasis are the main reasons for the high mortality of liver cancer, which involve the interaction of tumor stromal cells and malignant cells. Cancer-associated fibroblasts (CAFs) are one of the major constituents of tumor stromal cells affecting tumor growth, invasion, and metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Wentao, Liang, Shufang, Cheng, Binbin, Ling, Changquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636329/ https://www.ncbi.nlm.nih.gov/pubmed/34868982 http://dx.doi.org/10.3389/fonc.2021.763519

Ejemplares similares

Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
por: Yao, Man, et al.
Publicado: (2023)

Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity
por: Jia, Wentao, et al.
Publicado: (2020)

The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways
por: Liang, Shufang, et al.
Publicado: (2018)

Corrigendum to “The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways”
por: Liang, Shufang, et al.
Publicado: (2022)

Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
por: Xi, Sheng-Yan, et al.
Publicado: (2018)

Hypoxia-induced exosomes facilitate lung pre-metastatic niche formation in hepatocellular carcinoma through the miR-4508-RFX1-IL17A-p38 MAPK-NF-κB pathway
por: Jia, Wentao, et al.
Publicado: (2023)

Effect and Molecular Mechanisms of Jiedu Recipe on Hypoxia-Induced Angiogenesis after Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
por: Lin, Wanfu, et al.
Publicado: (2021)

Prognostic Value and Potential Immunoregulatory Role of SCARF1 in Hepatocellular Carcinoma
por: Patten, Daniel A., et al.
Publicado: (2020)

Activation of apoptosis in hepatocellular carcinoma by the Chinese traditional medicine Hu Qisan
por: ZENG, XIANGJUN, et al.
Publicado: (2013)

Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer
por: Lin, Xiang, et al.
Publicado: (2023)

Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
por: Wei, Lai, et al.
Publicado: (2022)

Single-cell RNA sequencing and traditional RNA sequencing reveals the role of cancer-associated fibroblasts in oral squamous cell carcinoma cohort
por: Wu, Lin, et al.
Publicado: (2023)

Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression
por: Zhang, Ying, et al.
Publicado: (2022)

A Mouse Model of Damp-Heat Syndrome in Traditional Chinese Medicine and Its Impact on Pancreatic Tumor Growth
por: Jiao, Juying, et al.
Publicado: (2022)

Role of Tetraspanins in Hepatocellular Carcinoma
por: Cai, Sicheng, et al.
Publicado: (2021)

Research Progress in Liver-Regenerating Microenvironment and DNA Methylation in Hepatocellular Carcinoma: The Role of Traditional Chinese Medicine
por: Wang, Minggang, et al.
Publicado: (2020)

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma
por: Li, Yuyao, et al.
Publicado: (2022)

Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
por: Dai, Weiyu, et al.
Publicado: (2021)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review
por: Zheng, Huilan, et al.
Publicado: (2023)

Impact of Traditional Chinese Medicine on Prognosis of Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study
por: Yuan, Huixin, et al.
Publicado: (2023)

The Effectiveness of Traditional Chinese Medicine Combined With Surgery to Treat Granulomatous Mastitis: A Propensity-Matched Analysis
por: Sawuer, Reziya, et al.
Publicado: (2022)

Identification of Traditional Chinese Medicine Constitutions and Physiological Indexes Risk Factors in Metabolic Syndrome: A Data Mining Approach
por: Tang, Yanchao, et al.
Publicado: (2019)

The Biological Functions and Clinical Values of Exosomal Circular RNAs in Hepatocellular Carcinoma
por: Zhao, Ying, et al.
Publicado: (2022)

Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma
por: Zhu, Xinyu, et al.
Publicado: (2021)

Impact of treatment-duration-ratio of traditional Chinese medicine on survival period of primary liver cancer —A real-world study
por: Cheng, Simo, et al.
Publicado: (2022)

Immune Checkpoint Blockade in Chinese Patients With Hepatocellular Carcinoma: Characteristics and Particularity
por: Wu, Yaoqiang, et al.
Publicado: (2022)

Review of the Effects and Safety of Traditional Chinese Medicine in the Treatment of Cancer Cachexia
por: Xu, Binbin, et al.
Publicado: (2021)

Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022)

Protective Role of Decorin in Primary Hepatocellular Carcinoma
por: Reszegi, Andrea, et al.
Publicado: (2020)

ESTABLISHMENT AND EVALUATION OF ORTHOTOPIC HEPATOCELLULAR CARCINOMA AND DRUG-INDUCED HEPATOCELLULAR CARCINOMA IN MICE WITH SPLEEN-DEFICIENCY SYNDROME IN TRADITIONAL CHINESE MEDICINE
por: Luo, Haoxuan, et al.
Publicado: (2016)

ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma
por: Zhang, Yu, et al.
Publicado: (2022)

Role of the HIF-1α/BNIP3 Signaling Pathway in Recurrent Hepatocellular Carcinoma and the Mechanism of Traditional Chinese Medicine
por: Liu, Sizhe, et al.
Publicado: (2023)

Copper metabolism and hepatocellular carcinoma: current insights
por: Zhou, Cheng, et al.
Publicado: (2023)

Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection
por: Weng, Li, et al.
Publicado: (2012)

Meta-Analysis of Astragalus-Containing Traditional Chinese Medicine Combined With Chemotherapy for Colorectal Cancer: Efficacy and Safety to Tumor Response
por: Lin, Shuang, et al.
Publicado: (2019)

A Case–Control Study of ADCY9 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in the Chinese Han Population
por: Chao, Xu, et al.
Publicado: (2020)

Elucidating the mechanism behind and investigating the efficacy of Traditional Chinese Medicine and Traditional Tibetan Medicine in combination with standard therapeutics in hepatocellular carcinoma and cholangiocarcinoma in vitro
por: Suo, Huizhen, et al.
Publicado: (2022)

Use of radiomics containing an effective peritumoral area to predict early recurrence of solitary hepatocellular carcinoma ≤5 cm in diameter
por: Wang, Fang, et al.
Publicado: (2022)

Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
por: Kowalik, Marta Anna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2ephkcd338s88qutvjs0f22iou